General Discussions

USPSTF Advises Men on Prostate Cancer Screening

By LISA SCHULMEISTER, RN, MN, APRN-BC, FAAN
PUBLISHED THURSDAY, JANUARY 1, 1970
Updated United States Preventive Services Task Force (USPSTF) guidelines on prostate cancer screening were recently published in Cancer.

The newest USPSTF recommendation calls for individualized decision making about whether to be screened for the disease after a discussion with a clinician. In doing so, each man has an opportunity to understand the potential benefits and harms of screening, and to incorporate his values and preferences into his decision.
The task force recommends that clinicians inform men ages 55-69 years old about the potential benefits and harms of prostate-specific antigen (PSA)–based screening for prostate cancer.

Although screening offers a small potential benefit of reducing the chance of dying of prostate cancer, many men will experience potential harms associated with screening. These can include: false-positive results that require additional testing and possible prostate biopsy; overdiagnosis and overtreatment; and treatment complications, such as incontinence and impotence.

The USPSTF recommends against PSA-based screening for prostate cancer in men age 70 years and older.

The task force also issued detailed recommendations on screening for African American men, men with a family history of prostate cancer, and other higher risk populations.

The updated 2017 USPSTF prostate cancer screening guidelines are available here.
Start a discussion
You must log in to use this feature, please click here to login.
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.